2031, Oral Spray Market Research Report Booming Worldwide - Benzinga

NPHC Stock  USD 0.0001  0.00  0.00%   
About 55% of Nutra Pharma's shareholders are presently thinking to get in. The analysis of overall sentiment of trading Nutra Pharma Corp pink sheet suggests that some investors are interested at this time. The current market sentiment, together with Nutra Pharma's historical and current headlines, can help investors time the market. In addition, many technical investors use Nutra Pharma Corp stock news signals to limit their universe of possible portfolio assets.
  
2031, Oral Spray Market Research Report Booming Worldwide Benzinga

Read at news.google.com
Google News at Macroaxis
  

Nutra Pharma Fundamental Analysis

We analyze Nutra Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nutra Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nutra Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Gross Profit

Gross Profit Comparative Analysis

8.5K5.5M1.2M125.4K100%
Nutra Pharma is currently under evaluation in gross profit category among its peers. Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

Peers

Trending Equities

AA  1.49   
0%
46.0%
UPS  1.03   
0%
32.0%
CVX  0.74   
0%
23.0%
AAPL  0.18   
0%
5.0%
BBY  0.13   
0%
4.0%
T  0.08   
2.0%
0%
IBM  0.51   
15.0%
0%
MET  0.63   
19.0%
0%
HD  0.95   
29.0%
0%
CVS  1.40   
43.0%
0%
AAL  1.44   
45.0%
0%
TGT  1.44   
45.0%
0%
WFC  2.30   
72.0%
0%
S  2.73   
85.0%
0%
C  2.94   
92.0%
0%
INTC  3.19   
100.0%
0%

Complementary Tools for Nutra Pink Sheet analysis

When running Nutra Pharma's price analysis, check to measure Nutra Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutra Pharma is operating at the current time. Most of Nutra Pharma's value examination focuses on studying past and present price action to predict the probability of Nutra Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutra Pharma's price. Additionally, you may evaluate how the addition of Nutra Pharma to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
News Freq…Investor S…